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Abstract
Previous neuroimaging studies of youth with bipolar disorder(BD) have identified abnormalities in 
emotion regulation circuitry. Using data from the Longitudinal Assessment of Manic Symptoms 
Cohort (a clinical sample recruited for behavioral and emotional dysregulation), we examined the 
impact of BD and medication on activation in these regions. Functional neuroimaging data were 
obtained from 15 youth with BD who currently were unmedicated with a mood stabilizer or 
antipsychotic (U-BD), 19 youth with medicated BD (M-BD), a non-bipolar clinical sample with 
high rates of disruptive behavioral disorders (non-BD, n=59), and 29 healthy controls (HC) while 
they were shown task-irrelevant morphing emotional faces and shapes. Whole brain analysis was 
used to identify clusters that showed differential activation to emotion vs. shapes across group. To 
assess pair-wise comparisons and potential confounders, mean activation data were extracted only 
from clusters within regions previously implicated in emotion regulation (including amygdala and 
ventral prefrontal regions). A cluster in the right inferior frontal gyrus (IFG) showed group 
differences to emotion vs. shapes (159 voxels, corrected p<.05). Within this cluster, U-BD youth 
showed decreased activation relative to HC (p=.007) and non-BD (p=.004) youth. M-BD also 
showed decreased activation in this cluster relative to HC and non-BD youth, but these differences 
were attenuated. Results were specific to negative emotions, and not found with happy faces. IFG 
findings were not explained by other medications (e.g. stimulants) or diagnoses. Compared to both 
HC and a non-BD sample, U-BD is associated with abnormally decreased right IFG activation to 
negative emotions.
Keywords
bipolar disorder; functional MRI (fMRI); psychopharmacology; neuroimaging; emotion regulation
Objectives of the Study and Background
Deficits in emotion regulation are central to the clinical diagnosis of bipolar disorder (BD). 
The underlying neurobiology of these deficits is hypothesized to involve abnormally 
increased activation of limbic regions coupled with decreased activation of regulatory 
prefrontal circuitry(Chen et al., 2011; Womer et al., 2009). Supporting this hypothesis, BD 
in youth has been associated with abnormalities in amygdala and prefrontal activation 
during emotion processing tasks. Specifically, several groups have found amygdala 
hyperactivation in youth with BD during emotional processing(Garrett et al., 2012; Kim et 
al., 2012; Pavuluri et al., 2007; Rich et al., 2006). Abnormalities have also been found in 
regions including ventrolateral prefrontal cortex(VLPFC), orbitofrontal cortex(OFC), and 
anterior cingulate cortex(ACC) during emotion processing, though the direction of these 
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abnormalities differs according to task and study population(Brotman et al., 2013; Dickstein 
et al., 2007; Ladouceur et al., 2011; Pavuluri et al., 2009). Limited studies with multiple 
patient groups have shown findings to be specific to BD, and not simply a marker of 
psychopathology(Passarotti et al., 2010b; Thomas et al., 2012). While medications seem to 
have a normalizing effect (reducing differences between activation in youth with BD versus 
healthy controls), few studies compare medicated and non-medicated youth(Hafeman et al., 
2012; Singh & Chang, 2012).
The current study examined the effects of diagnosis and psychotropic medication on neural 
activation during an emotional processing task in a subset of the Longitudinal Assessment of 
Manic Symptoms(LAMS) cohort, behaviorally and emotionally dysregulated youth who 
have been followed longitudinally(Findling et al., 2010; Horwitz et al., 2010). Participants in 
the parent cohort study(n=707) were recruited from 9 clinical settings at four 
sites(Pittsburgh, Cincinnati, Cleveland, and Columbus), preferentially selected based on an 
elevated score on a screen for deficits in behavior, emotion and energy regulation(Parent 
General Behavioral Inventory-10, PGBI-10)(Youngstrom et al., 2008). Follow-up is ongoing 
for over 80% of these participants, with biannual assessments of clinical symptoms, 
diagnoses and functional impairments. The aim of the LAMS study is to describe 
abnormalities in behavioral and emotional regulation and arousal over time, and ultimately 
to predict progression of functional impairment and disorder. As part of this aim, functional 
neuroimaging data were collected on a subset of youth at three sites(Pittsburgh, Cincinnati, 
and Cleveland) while engaging in a number of tasks, including implicit emotion processing.
Our analyses capitalized on several key attributes of this cohort. The sample was large 
enough to include a number of youth with BD who were currently not medicated with an 
antipsychotic, antidepressant or mood stabilizing drug, thus permitting comparisons between 
youth with unmedicated BD(U-BD), medicated bipolar youth(M-BD), and healthy 
controls(HC). Because recruitment was not based on diagnosis, LAMS included youth who 
did not meet criteria for BD(non-BD). This unique comparison group allowed us to assess 
the specificity of neuroimaging findings for BD, and to test whether such results could be 
explained by co-morbidity.
The current study tested the following hypotheses: (1) youth would activate the amygdala 
and prefrontal regions (as measured by BOLD signal) in response to emotional stimuli (vs. 
morphing shapes); (2) these activation patterns would differ across groups defined by 
diagnosis and medication status; and (3) differences would be most prominent in U-BD 
(versus HC), attenuated (but still present) in M-BD, and even less robust in non-BD. 
Specifically, we hypothesized that amygdala activation would be elevated in bipolar youth 
(U-BD>M-BD>non-BD≥HC), while prefrontal activation would show the opposite pattern 
(U-BD<M-BD<non-BD≤HC). We also assessed the degree that abnormalities differed 
across specific emotional stimuli, and the extent to which neuroimaging findings were 
related to mood state.
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A subset of the initial LAMS cohort(n=123) was recruited to participate in the neuroimaging 
component of the LAMS follow-up study. Additionally, 32 age- and gender-matched HC 
were scanned for comparison. Informed consent was obtained from parents or guardians 
after the nature of the study had been fully explained, and youth provided written informed 
assent. Participants received monetary compensation and a framed structural brain image. 
This investigation was carried out in accordance with the latest version of the Declaration of 
Helsinki, and the study design was approved by the appropriate Institutional Review Boards.
Exclusion criteria included pregnancy, inability to participate in scan (claustrophobia, metal 
objects in the body), positive urine drug and/or salivary alcohol screen on scan day, alcohol/
substance abuse in the past three months, severe systemic medical illness, neurological 
disorders, history of head trauma with loss of consciousness, IQ<70(Weschler, 1999), visual 
disturbance (<20/40 Snellen visual acuity), inability to complete questionnaires in English, 
history of physical/sexual abuse, or autistic spectrum disorders/developmental delays.
Data from 30 LAMS youth and three HC were excluded due to data loss and/or excessive 
head movement (>4mm, as used in previous studies studies(Bebko et al., 2013)), yielding 
usable scans from 93 LAMS participants and 29 healthy controls. Compared to included 
youth, those excluded were younger (p=.03) and had lower IQs (p=.0001); they were more 
likely to have disruptive behavior disorders (DBD) (p=.03) and unmedicated ADHD (p=.
004), but did not differ according to group (U-BD, M-BD, N-BD, and HC) (p=.15). (Table 
S1).
Assessment
Baseline assessments gathered demographic data including age, sex, IQ and parents' 
education. The Family History Screen(Weissman et al., 2000) tracked 15 psychiatric 
disorders in biological parents, and included two questions to assess for lifetime parental 
history of mania. Diagnoses were determined at baseline and every six months using the 
Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and 
Life Version with WASH-U mood supplement (K-SADS-PL-W)(Kaufman et al., 1997). 
During these biannual assessments, parents also completed the PGBI-10M. The PGBI-10M 
score nearest the scanning session (within 6 months) was used. PGBI-10M scores were very 
stable over the year immediately preceding scan day(Bebko et al., 2013).
On scanning day, the youth and a parent/guardian completed the Kiddie Schedule for 
Affective Disorders and Schizophrenia for School-Age Children Mania Rating 
Scale(KMRS) (Axelson et al., 2003) and Depression Rating Scale(KDRS)(Kaufman et al., 
1997), to assess for hypomanic/manic and depressive symptom severity, respectively. 
Interviewers determined summary scores based on all available information. Additional 
rating scales were administered, including the Screen for Childhood Anxiety Related 
Disorders(SCARED) and the Moods and Feelings Questionnaire(MFQ). Psychotropic 
medications taken within the past 24 hours were also recorded.
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Participants were categorized into four groups: U-BD (n=15), M-BD (n=19), non-BD 
(n=59), and HC (n=29). The mean age of the participants at time of scan was 13.6(±2.1) 
years, and 57% were male. Groups did not differ significantly according to age, gender, IQ, 
or socioeconomic status; however, sites differed on rates of HC recruitment(Tables 1 and 
S3). Approximately 1/3 of the clinical sample had DBD, including oppositional defiant 
disorder, conduct disorder, and DBD NOS, and 2/3 of the clinical sample was diagnosed 
with ADHD (Tables 1 and S2). Forty-seven percent (28/59) of the non-BD youth had a 
current or previous diagnosis of depressive disorder. Most bipolar youth were diagnosed 
with BD-I (21/34); the remainder fit criteria for BD-NOS, according to previously described 
criteria (Birmaher et al., 2006). We included youth with BD-NOS due to previous work 
indicating similarities in demographics, clinical features, and family history across the 
bipolar spectrum (Axelson et al., 2006; Hafeman et al., 2013).
All M-BD youth were on an antipsychotic and/or mood stabilizer medication (lithium or 
antiepileptic agent); six were also on an antidepressant medication, and 10 were on a 
stimulant (Table 1). By definition, the U-BD youth were not medicated with mood-altering 
medication; however, six of the 15 youth took medication for ADHD (non-stimulant (n=2) 
or stimulant (n=4)). Most non-BD youth were also on at least one psychotropic medication.
Groups differed significantly on measures of depressive and manic symptoms at time of 
scan (PGBI-10M, KMRS, KDRS, and MFQ), but not anxiety (Table S3). U-BD vs. M-BD 
youth had higher KDRS scores (p=.001; Table S4).
Dynamic Faces Paradigm
A block-design emotional dynamic faces task evaluated implicit processing of emotional 
stimuli. Participants watched a series of faces that morphed from neutral to full expression 
of emotion (happy, sad, fearful, or angry) in 1 second. During control blocks, a luminance-
equated shape morphed into a larger shape. Participants identified the foreground color, 
rendering the emotion task-irrelevant. The subject was shown three blocks for each of the 
four emotions (12 stimuli per block), and six control blocks (6 stimuli per block), pseudo-
randomized so that a single emotion block was not repeated sequentially. This task robustly 
activates the amygdala and prefrontal emotion processing circuitry in adults(Herringa et al., 
2013).
Neuroimaging Analysis
Data were preprocessed and analyzed using Statistical Parametric Mapping software (SPM8 
http://www.fil.ion.ucl.ac.uk/spm). We used a whole brain analytic approach to assess task 
activation, which we define as the difference in BOLD signal between emotion blocks and 
control (shape) blocks (Hypothesis 1); we next assessed differences in task activation 
between groups (Hypothesis 2). Our a priori regions of interest were the amygdala and 
prefrontal regions previously implicated in emotion regulation(Phillips et al., 2008; 
Strakowski et al., 2012): ACC, OFC(BA 11), and VLPFC(BA 47). Thus additional analyses 
(Hypothesis 3 and Supplemental) were only conducted for clusters with peak voxels in these 
regions.
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Hypothesis 1 - Activation of Amygdala and Prefrontal Regions
Using SPM8, we assessed whole brain activation patterns to emotions vs. shapes across the 
entire study population (n=122), using a 1-sample t-test and collapsing across group. To 
adjust for multiple comparisons, we reported only clusters that were Family Wise 
Error(FWE)-corrected p<.05, at both voxel- and cluster-wise levels.
Hypothesis 2 – Differential activation of these regions across group
We constructed multiple regression models in SPM8 to assess differences in activation to 
emotional faces vs. shapes between groups. Using a whole brain analysis, we identified 
voxels that showed significant (p<.01) between-group differences in both the unadjusted and 
covariate-adjusted (site, gender, age, and IQ) models. This conservative approach facilitated 
the identification of voxels that were robust to potential confounding factors. To correct for 
multiple comparisons, we used a cluster-wise threshold determined by Monte Carlo 
simulations implemented in AlphaSim, to maintain an alpha of .05; clusters were only 
considered significant if they were larger than the determined threshold(≥146 voxels). This 
validated technique accounts for spatial correlations between BOLD signal changes in 
neighboring voxels(Ward, 2002).
Hypothesis 3 – Specific Pair-Wise Comparisons
To determine which pair-wise comparisons explained the group differences observed above, 
mean BOLD signal change parameter estimates were extracted from significant cluster(s) 
(generated from Hypothesis 2) with peak voxels in the hypothesized regions. A general 
linear model (PROC GLM in SAS 9.2) was used to further assess pair-wise contrasts (e.g. 
M-BD vs. HC), adjusting for site, age, gender, and IQ. Because we only extracted from 
significant clusters, reported p-values are not spatially corrected for multiple comparisons; 
however, we used the Tukey test to correct for six pair-wise comparisons across four groups. 
The impact of parental history of mania and parental education on mean cluster activation 
was determined by entering these variables separately into the group-adjusted emotion vs. 
shapes model in SAS 9.2.
Further Analyses
One strength of the LAMS cohort is the heterogeneity of the youth, but this also leads to 
multiple alternative explanations for the observed results. To address several possible 
confounds, including co-morbidity, stimulant medication, type of bipolar diagnosis, task 
performance, and clinical state, we conducted the following analyses in SAS 9.2 on 
extracted regions from Hypothesis #2. First, we entered each variable into a multivariable 
model, adjusting for group and demographics, to establish whether (1) the variable 
significantly predicted cluster activation and (2) group was still significant after adjustment. 
Second, when possible, we assessed the impact of group in a subset of the population not 
affected by the potential confound, to determine whether results were driven by this 
variable. To address the impact of task performance, we re-ran models (in SAS 9.2) on the 
subset of youth with accuracy >80%.
To determine individual emotion effects, emotion-specific activation data were extracted 
from the significant cluster(s) identified in Hypothesis 2. General linear models were then 
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constructed in SAS 9.2 to assess between-group differences for each emotion. Results of 
these supplemental analyses are discussed briefly in the text, and detailed results are given in 
the Supplemental Appendix.
A number of measures were utilized to address biases that may arise in multisite 
neuroimaging studies. As recommended by the Biomedical Informatics Research Network 
(BIRN; http://www.nbirn.net), a BIRN phantom was utilized monthly at all three sites to 
ensure longitudinal scanner signal stability. In addition, scan site was used as a covariate in 
the SPM8 analysis (Hypothesis 2) and the GLM in SAS 9.2 (Hypothesis 3). We also 
conducted sensitivity analyses to determine whether observed patterns of between-group 
differences in activity were driven by a particular site, by sequentially removing each site 
and rerunning primary analyses in SAS 9.2.
Results
Hypothesis 1
As predicted, the task (emotions vs. shapes) diffusely activated multiple brain regions, most 
prominently the right fusiform gyrus, bilateral amygdala, and bilateral inferior frontal gyrus 
(IFG) (FWE-corrected p<.05) (Figure 1, Table 2). Significant activation was also observed 
in bilateral middle and superior temporal regions, as well as the left parahippocampal gyrus.
Hypothesis 2
Significant group differences to emotions vs. shape were found in the right IFG (peak voxel 
in the VLPFC), right cuneus, right middle cingulate cortex, and left insula (voxel-wise p<.
01, corrected p<.05) (Table 3). These clusters were robust to confounding, meaning that 
voxels were significant in both the unadjusted and covariate-adjusted models. Since the peak 
voxel of the IFG cluster was within an a priori region of interest (VLPFC), we extracted 
mean activation data for each participant from this cluster for further analyses (Figure 2a).
Hypothesis 3
While both the HC and non-BD youth showed mean activation in the extracted right IFG 
cluster during emotions vs. shapes (p<.05), the U-BD group showed deactivation in response 
to emotional stimuli (p<.05). Relative to both HC and non-BD youth, the U-BD showed 
decreased mean activation which was significant after correcting for multiple comparisons 
(corrected p<.01). As predicted, activation in the M-BD youth was intermediate between U-
BD and non-BD. No significant differences were observed between HC and non-BD groups. 
Covariate-adjusted results are shown in Figure 2b. Group effects remained significant after 
further adjustment for parental education and parental history of mania.
Further Analyses
Group effects remained significant following sequential adjustment for co-morbidity 
(ADHD, DBD, depression, and anxiety), stimulant usage, and type of bipolar disorder; 
additionally, none of these variables independently predicted cluster activation. Results from 
Hypothesis 3 were replicated in (1) the subgroup without co-morbidity and (2) the subgroup 
of youth not on a stimulant medication, indicating that these factors did not drive observed 
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findings. Additionally, results from Hypothesis 3 were replicated in youth with BD-I 
(excluding BD-NOS), indicating that sub-syndromal BD was not driving observed results. A 
sensitivity analyses to determine whether results were driven by a particular site indicated 
that group differences remained significant in each two-site subgroup (all p<.05).
Effect of Individual Emotions
Supplementary analysis assessing the activation to each emotion indicated that there were 
group effects to fearful (F=4.08, p=.009), angry (F=2.48, p=.06), and sad faces (F=6.06, p=.
0007), but not happy faces (F=0.72, p=.54). Thus results for emotions vs. shapes appear to 
be driven by neural responses to negative emotions (Figure S1).
Effect of clinical state
To determine whether the abnormality in the extracted IFG cluster correlated with current 
mood state, we sequentially entered both log-transformed clinician-derived (KMRS and 
KDRS) and self-report scales (MFQ and SCARED) into the Hypothesis 3 emotions vs. 
shapes model in SAS 9.2. Adjustment for these variables did not significantly impact the 
effect of group, indicating that between-group differences were not explained by clinical 
state. However, KDRS scores were positively correlated with IFG cluster activation (t=2.52, 
p=.01). While KMRS and PGBI-10 scores did not predict activation in the entire population, 
both were negatively correlated with IFG cluster activation in the bipolar sample (KMRS: 
t=-2.23, p=.03, PGBI-10: t=-2.55, p=.02). Thus exploratory results indicate that deficits in 
positive affect regulation were associated with decreased right IFG activation (in the bipolar 
sample), while depressive symptoms were associated with increased activation. Other scales 
(MFQ, SCARED) did not significantly predict cluster activation, and adjustment for these 
variables did not appreciably change the effect of group.
Effect of Task Performance
There were a significant number of participants with accuracy less than 80% on this task 
(n=49); these youth were more likely to be in the clinical sample (vs. HC) (p<.0001), 
although bipolar diagnosis (and medication status) did not significantly affect performance 
(Table S3). Much of the poor performance was due to missed trials. Three of the participants 
did not have any response data recorded, and n=7 had no response data for the majority of 
the trials (likely due to an error in ePrime). Further analyses determined that accuracy, 
reaction time, or response rate did not significantly impact IFG cluster activation, and 
adjustment for these variables did not appreciably change the effect of group. To ensure that 
results were not attributable to youth with poor accuracy, results from Hypothesis 3 were 
replicated in the sub-population of youth (n=75) who had accuracy >80% (Supplemental 
Appendix).
Discussion
We found deactivation of the right IFG (peak voxel in the VLPFC) during processing of 
emotional faces versus shapes in youth with U-BD, as compared to activation in HC and 
non-BD youth. Qualitatively similar differences were observed in youth with M-BD versus 
HC and non-BD youth, but these differences were attenuated. Observed IFG activation was 
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negatively correlated with PGBI-10 and KMRS scores, and positively correlated with KDRS 
scores, pointing to a possible relationship between IFG deactivation and manic state. Given 
the role of the VLPFC in emotion regulation(Phillips et al., 2008), these results support the 
hypothesis that youth with BD show abnormalities in emotion regulation circuitry.
The VLPFC is emerging as a region that, given its role in emotion regulation, is potentially 
important for the pathophysiology of BD(Foland-Ross et al., 2012; Strakowski et al., 2011). 
Two recent meta-analyses found that BD in adults was associated with decreased VLPFC 
activation relative to healthy controls(Chen et al., 2011) and adults with major depressive 
disorder(Delvecchio et al., 2012). Additionally, decreased VLPFC activation correlated with 
manic symptomatology(Chen et al., 2011), and normalized with treatment in youth with BD 
during a response inhibition task(Pavuluri et al., 2010).
Current findings build on this previous work in several important ways. Our results extend 
conclusions of previous meta-analyses from predominately adult populations to a sample of 
bipolar youth, indicating that the VLPFC might have an important role in the early 
pathophysiology of BD. The findings that this abnormality is correlated with manic 
symptoms and attenuated by medication indicates that VLPFC activation during this 
emotion processing task might be an important marker of treatment and/or clinical state; this 
builds on work by Pavuluri et al. (2010) that showed a similar finding during a response 
inhibition task (albeit in the left VLPFC). In addition, our sample provides the unique 
opportunity to compare bipolar youth to a non-BD clinical sample; this allows us to 
conclude that our observed results are specific to BD, and not simply attributable to co-
morbidity of the sample. Of note, previous work has also implicated the VLPFC in response 
inhibition(Aron et al., 2004), and has shown decreased VLPFC activation in youth with 
ADHD, which is ameliorated by stimulant medication(Rubia et al., 2011). In our sample, 
diagnosis of ADHD and stimulant medication did not predict VLPFC activation, likely due 
to the nature of the task (emotional faces vs. response inhibition).
Contrary to expectations, while our task led to robust activation of the amygdala across 
groups, no between-group difference was observed in the amygdala. One possible 
explanation for this is the likely attenuation of amygdala BOLD signal during each block via 
repetition suppression (associated with repeated exposures to the same face stimuli), which 
might have obscured between-group differences(Phillips et al., 2001). Thus it is possible that 
BD youth initially had a greater magnitude of amygdala activation, but due to attenuation 
within and across blocks, these differences were not observed. While most studies have 
shown abnormalities in amygdala activation in bipolar youth during emotion processing, 
there are certainly exceptions(Brotman et al., 2010; Passarotti et al., 2010a). A recent study 
found that BD is associated with a decreased ability of the amygdala to modulate in response 
to increasing intensity of emotional faces(Deveney et al., 2014). Given the dynamic nature 
of the current task, it is possible that amygdala modulation differed across groups, while 
mean signal did not.
Differences across groups were driven by the hemodynamic response to negative emotions, 
and were not evident in response to happy faces vs. shapes. This is possibly due to the 
greater salience of the negative emotions (relative to happy faces) in the task. Previous work 
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also indicates that the VLPFC is particularly responsive to negative stimuli(Viinikainen et 
al., 2010), and involved in reappraisal of negative emotions(Wager et al., 2008). Additional 
regions of differential activation were observed in the right cuneus, right middle cingulate 
gyrus, and left insula. These findings are consistent with an analysis from a subset of this 
study population that focused on more posterior regions, and found that BD youth (relative 
to HC) showed decreased activation in primary visual cortex(Perlman et al., 2013).
This study had a number of strengths, facilitating these novel analyses. First, the large 
sample size, recruited selectively for deficits in behavioral and emotional regulation, 
included enough youths with U-BD and M-BD to assess the impact of both diagnosis and 
medication. Second, the non-BD clinical sample allowed us to test whether the IFG finding 
was specific to BD, or a general marker for psychopathology in youth. Third, the sample is 
well-characterized, both at time of scan and historically. Multiple diagnostic interviews have 
been conducted, improving diagnostic quality and covariate assessment. Thus potential 
confounders of the relationship between group and IFG activation, such as demographics, 
parental history of mania, and additional diagnoses, could be adequately tested.
This study also has a number of limitations. First, the U-BD youth were not currently 
medicated for BD, but they were not necessarily medication naïve, and several were on 
medication for ADHD. However, results were not driven by this potential confound: when 
youth on stimulants were excluded, the IFG activation differences between U-BD and HC 
were even more pronounced. Second, this multisite study used three different scanners, 
leading to increased noise. Results were not driven by a particular site, and adjustment for 
site did not appreciably change findings. Although site effects might have obscured more 
subtle findings, they were not responsible for the primary observed results. Third, task 
accuracy rates were fairly low: ≈2/3 of the sample had accuracy >80%. Because youth were 
exposed to the same emotional stimuli regardless of task accuracy, we did not exclude those 
with accuracy <80% from initial analysis. However, we used the conservative approach of 
re-running analyses after excluding these youth and results remained robust. Also, 
adjustment for accuracy and reaction time did not appreciably alter findings. Fourth, a 
significant proportion of youth were excluded due to excessive movement (33/155). While 
these youth differed significantly in terms of IQ and proportion with unmedicated ADHD, 
they did not differ according to group; thus it is unlikely that exclusion due to motion 
appreciably impacted our findings. Fifth, observational studies comparing unmedicated and 
medicated youth must be interpreted with some caution, since medications are not randomly 
assigned, and medication is likely correlated with severity of disorder. However, this 
confound would not explain the current pattern of results, since the most pronounced 
abnormalities are found in the unmedicated BD youth (who would likely be less severe than 
there medicated counterparts). Sixth, the sample size in the BD groups was fairly modest, 
which might have limited our power to appreciate certain between-group differences; 
additionally, this limitation made it impossible to assess the effects of individual 
medications on observed results.
In conclusion, BD was associated with abnormal IFG deactivation in response to negative 
emotional stimuli. The finding was ameliorated by medication and not found in a non-
bipolar clinical sample. Research increasingly implicates the deactivation of the VLPFC in 
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BD in adults, particularly in manic states. VLPFC deactivation to negative emotional stimuli 
might represent a potential biomarker to predict the development and trajectory of BD. 
Further work will assess longitudinal relationships between VLPFC activation and 
symptomatology in youth.
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• Bipolar youth show abnormal right IFG deactivation in response to emotional 
faces.
• IFG deactivation was most prominent in the unmedicated bipolar youth.
• IFG deactivation was not found in youth with non-bipolar psychopathology.
• Findings are not attributable to task performance or mood state.
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Task activation patterns to all emotions vs. shapes across the entire study sample (whole 
brain, FWE-corrected p<.05). Z-scores are labeled.
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a: Cluster showing differential activation across groups with peak voxel in the a priori 
region of interest (voxelwise p<.01, corrected p<.05).
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b: Mean activation values across group for the extracted region(159 voxels) for emotions vs. 
shapes. While both HC and non-BD youth showed significant activation in response to 
emotions vs. shapes, U-BD showed deactivation; p-values are corrected for multiple 
comparisons using the Tukey-Kramer method.
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Table 2
Regions of activation (whole brain, FWE-corrected p<.05). Regions k>50 listed below.
Region Peak Coordinates(MNI) FWE-corrected p t k
Fusiform gyrus(right) 40 -48 -22 <.001 21.57 8048
Amygdala(right) 18 -4 -18 <.001 14.39 1356
Amygdala(left) -22 -4 -18 <.001 12.43 739
IFG/BA 46(right) 52 28 18 <.001 8.46 836
IFG/BA 47(right) 34 32 16 <.001 8.05 148
Middle temporal gyrus(left) -54 -60 6 <.001 7.82 160
Parahippocampal gyrus(left) -16 -32 -4 <.001 7.67 167
Superior temporal gyrus(right) 48 -16 -10 <.001 6.79 169
IFG/BA 47(left) -38 26 -16 <.001 6.47 61
Superior temporal gyrus(left) -46 16 26 <.001 6.22 220
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Table 3
Whole brain results, found in both unadjusted and covariate-adjusted models. Based on ANOVA of group 
differences (across emotions vs. shapes), with voxel wise threshold p<.01, corrected to p<.05 using AlphaSim 
threshold(146 voxels)
Region Peak Coordinates(MNI) F k
Inferior Frontal Gyrus(right) 38 16 -16 6.35 159
Cuneus(right) 14 -84 14 8.18 441
Insula(left) -46 -24 18 6.76 155
Middle cingulate gyrus(right) 2 -36 38 6.48 162
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